Speaker: 

Sewit Araia, Pharm.D., PGY1 Pharmacy Resident, Geisinger Medical Center - has nothing to disclose

Moderator(s): 

Sarah F. Hale, Pharm.D., BCPPS; Director of Pharmacy, Geisinger Medical Center - has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe background on left ventricular assist devices  (LVAD) and associated pharmacological therapy 
• Summarize key takeaways from the ARIES-HM3 trial 
• Evaluate the use of aspirin in LVAD patients

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD; Brain Simpkins, PharmD; Jessica Milheim, CPhT and Nichole Varela Gonzalez, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.